Vor Biopharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $126,036,000.
Profit Margin
| 2018 | 0 | -4.15M | |
|---|---|---|---|
| 2019 | 0 | -11.44M | |
| 2020 | 0 | -43.33M | |
| 2021 | 0 | -68.78M | |
| 2022 | 0 | -90.77M | |
| 2023 | 0 | -117.86M |
VOR Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 3.49M | 8.96M | 4.45M | 1.38M | 91K | 0 |
Gross profit | -3.49M | -8.96M | -4.45M | -1.38M | -91K | 0 |
Operating exp. | ||||||
Research and development | 94.31M | 64.55M | 47.52M | 31.61M | 6.2M | 2.43M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 126.03M | 93.41M | 69.01M | 43.36M | 10.41M | 2.86M |
Operating income | -126.03M | -93.41M | -69.01M | -43.36M | -10.41M | -2.86M |
Other income (expenses), net | 8.17M | 1.32M | 119K | 29K | -422K | -289K |
Income before tax | -117.86M | -92.09M | -68.89M | -43.33M | -10.83M | -4.15M |
Income tax expense | 0 | -1.32M | -119K | 427.70K | 608K | -289K |
Net income | -117.86M | -90.77M | -68.78M | -43.33M | -11.44M | -4.15M |
Earnings per share | ||||||
Basic EPS | -1.75 | -2.29 | -1.85 | -1.17 | -0.31 | -0.73 |
Diluted EPS | -1.75 | -2.29 | -1.85 | -1.17 | -0.31 | -0.73 |
| Data source | Data source | Data source | Data source |